Treatment outcomes of sorafenib for first line or cytokinerefractory advanced ... - UroToday PDF Print
UroTodayThe objective of the present study was to document the treatment efficacy and safety of sorafenib in Japanese patients with advanced renal cellcarcinoma

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.